DBV Battles Aimmune for Share of Peanut Allergy Treatment Market
Last year, the FDA rejected DBV Technologies’ peanut allergy treatment and approved that of its…
14/04/2021 - 5 minutes
DBV Technologies
The 21 European Biotech Companies To Watch in 2021
As we enter 2021, the biotech industry is already bustling with activity. Here’s a list…
11/01/2021 - 11 minutes
DBV Technologies’ Peanut Allergy Patch Suffers FDA Setback
A request for market approval of a skin patch developed by French biotech DBV Technologies…
06/08/2020 - 3 minutes
DBV Technologies’ Peanut Allergy Treatment Hits FDA Setback
French biotech DBV Technologies’ bid for the US approval of a skin patch to treat…
25/03/2020 - 3 minutes
Get to Know 15 Awesome Biotechs in Paris
Paris attracts millions of tourists to see some of the world’s most iconic monuments: the…
18/02/2020 - 12 minutes
The Billion-Euro European Biotech Companies in 2018
Here’s the list of the European biotech companies, both public and private, that are worth…
29/10/2018 - 7 minutes
This Immunotherapy Could Be The First to Treat Milk Allergy in Children
DBV Technologies has shown in a Phase II trial that its skin patch could desensitize…
29/05/2018 - 2 minutes
DBV Technologies’ Milk Allergy Patch Helps Kids in a Phase II Trial
DBV Technologies' candidate could be the first treatment for allergies to cow milk after its…
27/02/2018 - 3 minutes
After Failed Trial, French Biotech Gets Good News for its Peanut Allergy Therapy
DBV Technologies has positive safety data supporting the approval of a treatment for peanut allergy…
20/11/2017 - 2 minutes
Peanut Allergy Trial Fails but French Biotech Keeps Pushing for Approval
DBV Technologies plans to go ahead with its peanut allergy treatment despite its failure to…
23/10/2017 - 2 minutes
French Biotech May Save Toddlers from Life-Threatening Peanut Allergy
The first French biotech to NASDAQ, DBV, is expanding the patient group for its promising…
02/08/2017 - 1 minute
What are the Best Countries to Recruit Biotech Talents in 2017?
Before the “who to recruit” phase, an important question is “where?” We ran through the…
15/03/2017 - 10 minutes
